Autoimmune lymphoproliferative syndrome with defective Fas: Genotype influences penetrance

American Journal of Human Genetics

Volumn 64, Issue 4, 1999, Pages 1002-1014

  Jackson, Christine E ^a   Fischer, Roxanne E ^a   Hsu, Amy P ^a   Anderson, Stacie M ^a   Choi, Youngnim ^a   Wang, Jin ^b   Dale, Janet K ^b   Fleisher, Thomas A ^c   Middelton, Lindsay A ^a   Sneller, Michael C ^b   Lenardo, Michael J ^b   Straus, Stephen E ^b   Puck, Jennifer M ^a,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; DISEASE SEVERITY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOPROLIFERATIVE DISEASE; PENETRANCE; PRIORITY JOURNAL;

EID: 0033361766     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302333     Document Type: Article

References (47)

1. Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM (1990) Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 86: 1084-1087
2. Arnold WJ (1993) Sarcoidosis. In: Kelley WN, Harris ED Jr., Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th ed. W. B. Saunders, Philadelphia, pp 1429-1434
3. Behrmann I, Walczak H, Krammer PH (1994) Structure of the human APO-1 gene. Eur J Immunol 24:3057-3062
4. Beltinger C, Kurz E, Böhler T, Schrappe M, Ludwig WD, Debatin KM (1998) CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 91: 3943-3951
5. Bettinardi A, Brugnoni D, Quiròs-Roldan E, Malagoli A, La Grutta S, Correra A, Notarangelo LD (1997) Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89:902-909
6. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, et al (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444
7. Cascino I, Fiucci G, Papoff G, Ruberti G (1995) Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706-2713
8. Cheng J, Liu C, Koopman WJ, Mountz JD (1995) Characterization of human Fas gene: exon/intron organization and promoter region. J Immunol 154:1239-1245
9. Cooper DN, Krawczak M (1995) Human gene mutation. BIOS Scientific Publishers, Oxford
10. Danis VA, Millington M, Hyland VJ, Grennan D (1995a) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Rα gene polymorphism. Clin Exp Immunol 99: 303-310
11. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D (1995b) Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 12:127-133
12. Davidson WF, Dumont FJ, Bedigian HG, Fowlkes BJ, Morse HC III (1986) Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J Immunol 136:4075-4084
13. Davignon JL, Budd RC, Ceredig R, Piguet PF, MacDonald HR, Cerottini JC, Vassalli P, et al (1985) Functional analysis of T cell subsets from mice bearing the lpr gene. J Immunol 135:2423-2428
14. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373:438-441
15. Drappa J, Vaishnaw AK, Sullivan KE, Chu J-L, Elkon K (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643-1649
16. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, et al (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
17. Fiucci G, Ruberti G (1994) Detection of polymorphisms within the Fas gene sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics 39:437-439
18. Galbraith GM, Pandey JP (1995) Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 96:433-436
19. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik S (1996) NMR structure and mutagenesis of the Fas (APO-1/ CD95) death domain. Nature 384:638-641
20. Inazawa J, Itoh N, Abe T, Nagata S (1992) Assignment of the human Fas antigen gene to 10q24.1. Genomics 14:821-822
21. Infante AJ, Britton HA, De Napoli T, Middelton LA, Lenardo MJ, Jackson CE, Wang J, et al (1998) The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome (ALPS) due to a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133:629-633
22. Ito M, Oiso Y, Murase T, Kondo K, Saito H, Chinzei T, Racchi M, et al (1993) Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus. J Clin Invest 91:2565-2571
23. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 133:227-233
24. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, et al (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448
25. Kasahara Y, Wada T, Niida Y, Yachie A, Seki H, Ishida Y, Sakai T, et al (1998) Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int Immunol 10:195-202
26. cg: a novel mutant gene. Int Rev Immunol 11:193-210
27. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS (1997) Mutations in the Fas antigen in patients with multiple myeloma. Blood 90:4266-4270
28. Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858-861
29. Liu C, Cheng J, Mountz JD (1995) Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310:957-963
30. Messer G, Kick G, Ranki A, Koskimies S, Reunala T, Meurer M (1994) Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology 189 (suppl 1):135-137
31. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
32. cg in the heterozygous state on different genetic backgrounds. Cell Immunol 148:91-102
33. Papoff G, Cascino I, Eramo A, Starace G, Lynch D, Ruberti G (1996) An N-terminal domain shared by Fas/Apo-1(CD95) soluble variants prevents cell death in vitro. J Immunol 156:4622-4630
34. Pensati L, Costanzo A, Ianni A, Accapezzato D, Iorio R, Natoli G, Nisini R, et al (1997) Fas/APO-1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology 113: 1384-1389
35. Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, Conley ME, et al (1997) Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89:1968-1977
36. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
37. Sarkar G, Yoon H-S, Sommer SS (1992) Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations. Genomics 13:441-443
38. Schur PH (1993) Clinical features of SLE. In: Kelley WN, Harris ED Jr., Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th ed. W. B. Saunders, Philadelphia, pp 1017-1042
39. Singh A, Ni J, Aggarwal BB (1998) Death domain receptors and their role in cell demise. J Interferon Cytokine Res 18: 439-450
40. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M, Strober W (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334-341
41. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, et al (1997) Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341-1348
42. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA (1997) A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 40:2207-2211
43. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976
44. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
45. Watzke HH, Wallmark A, Hamaguchi N, Giardina P, Stafford DW, High KA (1991) Factor X Santo Domingo: evidence that the severe clinical phenotype arises from a mutation blocking secretion. J Clin Invest 88:1685-1689
46. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P, Duff GW (1994) A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24:191-195
47. Yanagawa T, de Groot LJ (1996) HLA class II associations in African-American female patients with Graves' disease. Thyroid 6:37-39